灵活的聚乙烯纳米脂质体用于增强皮肤传递:弹性和亮化潜力
Hong Meng1, Jie Xiong1, Wenxin Hu1
1School of Light Industry Science and Engineering, Beijing Technology and Business University, Beijing 100048, P.R. China.
Current pharmaceutical biotechnology
|October 23, 2025
概括
这项研究开发了聚乙烯 (PTS) 柔性纳米脂质体 (FNL) 以改善皮肤传递. 优化的PTS FNL表现出增强的稳定性和透性,在化品应用中被证明是有效的.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 皮肤病学 皮肤病学
背景情况:
- 聚二 (PTS) 具有较差的水溶性和不稳定性,限制了其局部应用.
- 灵活的纳米脂质体 (FNL) 提供了一种潜在的解决方案,用于增强难溶性化合物的输送.
- 膜软化剂,如二糖酸盐被研究以改善纳米脂质体变形性和皮肤透性.
研究的目的:
- 开发和优化聚乙烯 (PTS) 柔性纳米脂质体 (FNL) 以改善通过皮肤递送药物.
- 评估开发的PTS FNL的物理化学特性,稳定性和皮肤透性.
- 评估PTS FNL在改善皮肤的化品应用中的有效性.
主要方法:
- 使用单因子和直角实验设计,系统优化PTS FNL配方.
- 通过DLS,TEM和Turbiscan进行物理化学性质的表征,包括粒子大小,PDI,泽塔电位和形态学.
- 在体外和体内研究评估皮肤透,保留和人类志愿者的疗效.
主要成果:
- 优化的PTS FNL实现了高封装效率 (96.49%) 和合适的粒子大小 (60.11 nm).
- 在4°C和25°C下,FNL配方在三个月内表现出极好的稳定性.
- 试验室和体内研究证实了皮肤的优异透,保留和显著改善皮肤弹性和色度,没有不良影响.
结论:
- 增强的PTS FNL的可变性显著改善了皮肤间传递和稳定性.
- PTS FNL是用于化品应用的一个有前途的系统,特别是用于抗衰老和皮肤亮化.
- 这种脂质体方法提供了一种可行的策略,用于局部输送难溶活性成分.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
314
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
314
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
313
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
313
Modified-Release Drug Delivery Systems: Site-Targeted
130
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
130
Site-Targeted Drug Delivery Systems: Polymeric Carriers
125
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
125


